Oncolytics Biotech
ONCY
#9071
Rank
NZ$0.20 B
Marketcap
NZ$1.89
Share price
6.60%
Change (1 day)
52.70%
Change (1 year)

Earnings for Oncolytics Biotech (ONCY)

Earnings in 2025 (TTM): -NZ$43.04 Million

According to Oncolytics Biotech 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$42.63 Million a decrease over its 2023 earnings that were of -NZ$42.21 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oncolytics Biotech from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$43.04 Million0.96%
2024 -NZ$42.63 Million1.01%
2023 -NZ$42.21 Million23.39%
2022 -NZ$34.2 Million-1.98%
2021 -NZ$34.89 Million9.1%
2020 -NZ$31.98 Million22.64%
2019 -NZ$26.08 Million22.78%
2018 -NZ$21.24 Million4.1%
2017 -NZ$20.41 Million4.87%
2016 -NZ$19.46 Million8.75%
2015 -NZ$17.89 Million-37.06%
2014 -NZ$28.42 Million-26.2%
2013 -NZ$38.52 Million-37.39%
2012 -NZ$61.52 Million28.8%
2011 -NZ$47.76 Million46.02%
2010 -NZ$32.71 Million35.64%
2009 -NZ$24.12 Million-14.2%
2008 -NZ$28.11 Million-0.52%
2007 -NZ$28.25 Million24.6%
2006 -NZ$22.68 Million45.34%
2005 -NZ$15.6 Million-11.8%
2004 -NZ$17.69 Million115.36%
2003 -NZ$8.22 Million13.86%
2002 -NZ$7.22 Million-5.45%
2001 -NZ$7.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
NZ$37.70 B-90,559.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.45 B-32,390.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
-NZ$1.29 Billion 2,974.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-NZ$9.2 Million-77.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.60 B-8,750.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
-NZ$48.66 Million 16.73%๐Ÿ‡บ๐Ÿ‡ธ USA